期刊文献+

LSD1和EZH2蛋白表达与食管鳞癌术后预后相关性分析 被引量:5

Relationship between protein expression of LSD1 and EZH2 and prognosis in patients with esophageal aquamous cell carcinoma
原文传递
导出
摘要 目的表现遗传学是当前肿瘤生物学研究的热点,本研究探讨食管鳞状细胞癌癌组织中组蛋白赖氨酸特异性脱甲基酶1(lysine specific demethylase 1,LSD1)和Zeste基因增强子(enhancer of zeste homolog 2,EZH2)的蛋白表达与术后预后的相关性。方法收集2008-05-07-2009-8-20在安阳市肿瘤医院胸外科行食管癌根治术的食管鳞癌患者85例。选取食管鳞癌组织85例,淋巴结转移癌组织30例,癌旁组织30例。免疫组织化学法检测食管鳞癌组织、淋巴结转移癌组织、癌旁组织中LSD1和EZH2蛋白表达。采用χ2检验分析LSD1和EZH2蛋白表达与临床病理特征的关系;Spearman法分析LSD1和EZH2两者的相关性;Kaplan-meier法和Logrank-test检验分析LSD1和EZH2蛋白表达与术后总生存期(overall survival,OS)和无进展生存期(progression free survival,PFS)的关系,Cox模型多因素预后分析。结果LSD1在食管鳞癌组织和淋巴结转移癌组织中的高表达率分别为64.7%(55/85)和70.0%(21/30);癌旁组织均为少量阳性表达(低表达),主要位于增殖较旺盛的鳞状上皮基底部;LSD1在食管鳞癌组织、淋巴结转移癌组织的表达均高于癌旁组织(P<0.001,P=0.001),食管鳞癌组织与淋巴结转移癌组织中的表达差异无统计学意义,P=0.598。EZH2在食管鳞癌组织、淋巴结转移癌组织和癌旁组织中的高表达率分别为62.3%(53/85)、76.7%(23/30)和20.0%(6/30);EZH2在食管鳞癌组织、淋巴结转移癌组织的表达均高于癌旁组织(P<0.001,P=0.001),食管鳞癌组织与淋巴结转移癌组织中的表达差异无统计学意义,P=0.155。Spearman相关分析显示,LSD1和EZH2蛋白表达存在正相关,r=0.239,P=0.028。LSD1蛋白表达水平与pT分期(P=0.007)和分化程度(P=0.021)相关。EZH2蛋白表达水平与pT分期(P=0.022)、pN分期(P=0.046)和分化程度(P=0.018)相关。单因素分析显示,LSD1高表达患者的mOS和mPFS均低于低表达患者,均P<0.001。EZH2高表达患者的mOS和mPFS均低于低表 OBJECTIVE Epigenetic is a hot research topic in tumor biology. This study is to investigate the relation- ship between protein expression of LSD1 and EZH2 and postoperative prognosis in esophageal aquamous cell carcinoma (ESCC). METHODS The data from 85 patients with thoracic esophageal squamous cell carcinoma who underwent curative R0 esophagectomy from May 7,2008 to August 20,2009 in Anyang Cancer Hospital were retrospectively exam- ined. The LSD1 and EZH2 expression in ESCC tissues, lymph node metastasis carcinoma tissues and adjacent normal epi- thelia tissues were detected by immunohistochemical staining. Correlation of LSD1 and EZH2 expression and clinicopatho- logical factors were analyzed using Chi-squared test. Spearman method was used to analyze the correlation between LSD1 and EZH2. Survival curves were generated according to the Kaplan-meier method, and the statistical analysis was per- formed by Cox regression. RESULTS The high expression rates of LSD1 in esophageal squamous cell carcinoma tissues and lymph node metastasis carcinoma tissues were 64.7% (55/85), 70.0% (21/30) respectively. The adjacent tissues were a few positive expression (low expression), mainly in the squamous epithelial basal of relatively strong proliferation. The expression of LSD1 in ESCC tissues and lymph node metastasis carcinoma tissues were higher than in adjacent normal epithelia tissue (P〈0. 001 ;P= 0. 001). Comparison of ESCC tissues and lymph node metastasis carcinoma tissues, the differences were not statistically significant (P=0. 598). The high expression rates of EZH2 in esophageal squamous cell carcinoma tissues and lymph node metastasis carcinoma tissues were 62.3 % (53/85), 76.7 % (23/30) and 20.0 % (6/30) respectively. The expression of EZH2 in ESCC tissues and lymph node metastasis carcinoma tissues were higher than that in adjacent normal epithelia tissue (P〈0. 001 ;P=0. 001) ; Comparison of ESCC tissues and lymph node metastasis carci- noma tissues, the differences
出处 《中华肿瘤防治杂志》 CAS 北大核心 2016年第14期936-943,951,共9页 Chinese Journal of Cancer Prevention and Treatment
基金 国家自然科学基金〔青年科学基金项目(81201945)〕
关键词 食管肿瘤 组蛋白赖氨酸特异性脱甲基酶1 Zeste同源序列2的增强子 预后 esophageal neoplasms lysine specific demethylase 1 enhancer of zeste homolog2 prognosis
  • 相关文献

参考文献4

二级参考文献62

  • 1冯艳,宋立兵,郭宝红,廖雯婷,李满枝,刘万里,曾木圣,张玲.Bmi-1在乳腺癌组织中的表达及意义[J].癌症,2007,26(2):154-157. 被引量:67
  • 2Schiitte K, Bornschein J, Malfertheiner P. Hepatocellular carcinoma-epidemiological trends and risk factors. Dig Dis 2009, 27:80-92. 被引量:1
  • 3Li D, Mallory T, Satomura S. AFP-L3: a new generation of tumor marker for hepatocellular carcinoma. Clin Chim Acta 2001, 313:15-19. 被引量:1
  • 4Blum HE, Spangenberg HC. Hepatocellular carcinoma: an update. Arch Iran Med 2007, 10:361-371. 被引量:1
  • 5Wang J, Scully K, Zhu X, Cai L, Zhang J, Prefontaine GG, Krones A, Ohgi KA, Zhu P, Garcia-Bassets I, Liu F, Taylor H, Lozach J, Jayes FL, Korach KS, Glass CK, Fu XD, Rosenfeld MG. Opposing LSD1 complexes function in developmental gene activation and repression programmes. Nature 2007, 446:882-887. 被引量:1
  • 6Scoumanne A, Chen X. The lysine-specific demethylase 1 is required for cell proliferation in both p53-dependent and -independent manners. J Biol Chem 2007, 282:15471-15475. 被引量:1
  • 7Lira S, Janzer A, Becker A, Zimmer A, Schiile R, Buettner R, Kirfel J. Lysine-specific demethylase 1 (LSD1) is highly ex- pressed in ER-negative breast cancers and a biomarker pre- dicting aggressive biology. Carcinogenesis 2010, 31:512-520. 被引量:1
  • 8Hayami S, Kelly JD, Cho HS, Yoshimatsu M, Unoki M, Tsu- noda T, Field HI, Neal DE, Yamaue H, Ponder BA, Naka- mura Y, Hamamoto R. Overexpression of LSD1 contributes to human carcinogenesis through chromatin regulation in various cancers. Int J Cancer 2011, 128:574-586. 被引量:1
  • 9Chen PP, Li WJ, Wang Y, Zhao S, Li DY, Feng LY, Shi XL, Koeffler HP, Tong XJ, Xie D. Expression of Cyr61, CTGF, and WISP-1 correlates with clinical features of lung cancer. PLoS One 2007, 2:e534. 被引量:1
  • 10Guo X, Xiong L, Zou L, Zhao J. Upregulation of bone mor- phogenetic protein 4 is associated with poor prognosis in patients with hepatocellular carcinoma. Pathol Oncol Res 2012, 18:635-640. 被引量:1

共引文献25

同被引文献43

引证文献5

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部